Olive, Inc., a Columbus, Ohio-based healthcare-focused robotic process automation and artificial intelligence company, raised $32.8m in Series D funding round.
The round was led by Oak HC/FT and Ascension Ventures with participation from existing investors. In conjunction with the funding, Billy Deitch, Principal at Oak HC/FT, and John Kuelper, Investment Director at Ascension Ventures, will join the board of directors.
The company intends to use the funds to scale its AI solution, Olive, throughout healthcare organizations nationwide, and invest in new capabilities such as Pupil, its process mining tool, which will be launched at alpha sites this summer.
Led by Sean Lane, Founder and CEO, Olive is a healthcare-specific artificial intelligence and process automation company that allows organizations to improve efficiency and patient care while reducing administrative errors. Its AI solution acts as the intelligent router between systems and data by automating repetitive, high-volume tasks and workflows, providing interoperability.